TY - JOUR
T1 - Rare genotype combination of the serotonin transporter gene associated with treatment response in severe personality disorder
AU - Perroud, Nader
AU - Salzmann, Annick
AU - Saiz, Pilar A.
AU - Baca-Garcia, Enrique
AU - Sarchiapone, Marco
AU - Garcia-Portilla, Maria P.
AU - Carli, Vladimir
AU - Vaquero-Lorenzo, Concepción
AU - Jaussent, Isabelle
AU - Mouthon, Dominique
AU - Vessaz, Monique
AU - Huguelet, Philippe
AU - Courtet, Philippe
AU - Malafosse, Alain
PY - 2010/12
Y1 - 2010/12
N2 - The insertion deletion (ins/del) polymorphism of the serotonin transporter gene (5-HTTLPR) has been associated with several psychiatric phenotypes and antidepressant's response. We investigated, in a large cohort of 5,608 controls and subjects suffering from various psychiatric disorders, the frequency of haplotypes and corresponding genotypes combining the 5-HTTLPR and the other serotonin transporter promoter functional variant (rs25531). We showed that rs25531 lies 18bp 5' to the site where the 43bp (and not 44bp as previously described) ins/del defines the 14- and 16-repeat alleles. These polymorphisms should therefore be considered as four alleles instead of a triallelic unique locus. The very rare G-14/G-16 genotype was carried on by only three subjects. These are women with a history of suicide attempt with a psychiatric history strongly suggesting a borderline personality disorder. Two of them have shown a non-response to serotoninergic antidepressant. Interestingly, in one of them was observed a spectacular response after the introduction of bupropion. The genotyping droved our therapeutic approach, by preferring a dopaminergic over a serotoninergic agent. This study highlights the usefulness of studying very rare clinical cases as well as rare variants, in order to deal with the biological heterogeneity of spectral disorders.
AB - The insertion deletion (ins/del) polymorphism of the serotonin transporter gene (5-HTTLPR) has been associated with several psychiatric phenotypes and antidepressant's response. We investigated, in a large cohort of 5,608 controls and subjects suffering from various psychiatric disorders, the frequency of haplotypes and corresponding genotypes combining the 5-HTTLPR and the other serotonin transporter promoter functional variant (rs25531). We showed that rs25531 lies 18bp 5' to the site where the 43bp (and not 44bp as previously described) ins/del defines the 14- and 16-repeat alleles. These polymorphisms should therefore be considered as four alleles instead of a triallelic unique locus. The very rare G-14/G-16 genotype was carried on by only three subjects. These are women with a history of suicide attempt with a psychiatric history strongly suggesting a borderline personality disorder. Two of them have shown a non-response to serotoninergic antidepressant. Interestingly, in one of them was observed a spectacular response after the introduction of bupropion. The genotyping droved our therapeutic approach, by preferring a dopaminergic over a serotoninergic agent. This study highlights the usefulness of studying very rare clinical cases as well as rare variants, in order to deal with the biological heterogeneity of spectral disorders.
UR - http://www.scopus.com/inward/record.url?scp=78851471110&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78851471110&partnerID=8YFLogxK
U2 - 10.1002/ajmg.b.31118
DO - 10.1002/ajmg.b.31118
M3 - Article
C2 - 20862697
AN - SCOPUS:78851471110
SN - 1552-4841
VL - 153
SP - 1494
EP - 1497
JO - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics
JF - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics
IS - 8
ER -